Dr. Peter Kaiser is a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and a leading clinical researcher of retinal disorders. With contributions to 7 textbooks, 30 book...
Read More
Pharma Intelligence recently published a white paper titled “Rare Disease Trial Strategies” that piqued our team’s interest in how we may be able to help sponsors, CROs, and sites address some of the...
Read More
A recent study by WCG highlighted some of the top post-pandemic clinical trial enrollment challenges sites and sponsors are facing in 2022. Not surprisingly, COVID-19 has completely altered the way...
Read More
Rajat Agrawal, MD, MS is an ophthalmologist and retina specialist with over 25 years of experience between academia and industry. He has been published in leading ophthalmology journals, invited to...
Read More
The average cost of a phase 1 clinical trial is $4 million. At this early stage of drug development, patient recruitment delays can quickly drain a clinical trial budget. To keep timelines on track,...
Read More
BOSTON--(BUSINESS WIRE)--2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has completed its...
Read More
2020 On-site’s Industry and Scientific Advisory Board is continuing the important discussion around the patient experience and innovations in the ophthalmology industry. The group of ophthalmology...
Read More